8-K: DXP Enterprises Refinances Debt, Secures $205M for Growth
Debt Refinancing and Incremental Loan
DXP Enterprises has successfully refinanced its existing Term Loan B debt and secured an additional $205 million in incremental term loans, enhancing liquidity and supporting its acquisition strategy.
Summary
- DXP Enterprises, Inc. (DXPE) entered into Amendment No. 4 to its Term Loan and Security Agreement on December 16, 2025.
- The amendment provides for adjustments to certain financial ratio covenant compliance dates and $205 million in new incremental term loan commitments.
- After giving effect to the amendment and new loans, DXP has $848.0 million in outstanding borrowings under the Term Loan Agreement.
- The Term Loan B borrowings mature on October 13, 2030.
- The loans are priced at Term SOFR (with a floor of 1.00%) plus 3.25%, or base rate plus 2.25%.
- Proceeds from the 2025 Incremental Term Loans will be used to pay transaction fees and expenses, finance permitted acquisitions, replenish cash/repay ABL Obligations for acquisitions, and for general corporate purposes.
- The transaction is expected to generate an estimated $3.2 million in annual interest savings by repricing existing debt.
- The company reported sales growth from $1.0 billion in 2020 to $1.96 billion for the twelve months ended September 30, 2025.
- Covenant compliance adjusted EBITDA increased from $64.9 million in 2020 to over $225 million for the twelve months ended September 30, 2025.
- DXP will have $285 million in cash on the balance sheet at close of the transaction.
Sentiment
Score: 8
Explanation: The filing indicates a strong positive sentiment due to successful debt refinancing at a lower cost, significant capital raise for growth, and robust financial performance metrics (sales and EBITDA growth, healthy leverage ratio). The management comments reinforce a confident outlook for future acquisitions and strategic reinvestment.
Positives
- Secured an additional $205 million in incremental term loan commitments, increasing total borrowings to $848.0 million, providing enhanced liquidity.
- Repricing existing debt is estimated to generate $3.2 million in annual interest savings.
- The transaction supports the company's accelerating acquisition strategy and strategic reinvestment in the business.
- Maintains operational and financial flexibility for growth.
- Reported significant sales growth from $1.0 billion in 2020 to $1.96 billion for the twelve months ended September 30, 2025.
- Covenant compliance adjusted EBITDA increased substantially from $64.9 million in 2020 to over $225 million for the twelve months ended September 30, 2025.
- Pro forma net debt to EBITDA stands at a healthy 2.8:1 at the end of Q3, indicating improved leverage.
Risks
- Ability to obtain needed capital.
- Dependence on existing management.
- Leverage and debt service.
- Domestic or global economic conditions.
- Changes in customer preferences and attitudes.
- Uncertainties and contingencies, many of which are beyond the control of the Obligors, that may cause actual results to differ materially from projections.
Future Outlook
The company aims to close the year with strength and accelerate growth in 2026, with plans to pursue more acquisitions to scale DXP. The capital allocation strategy prioritizes growth investments, debt reduction with excess cash flow, and reinvestment in facilities, equipment, and technology.
Management Comments
- David R. Little, Chairman and Chief Executive Officer: "We are pleased to complete another successful refinancing, reinforcing DXPs strong financial foundation. Building on this momentum, we aim to close the year with strength and accelerate growth in 2026. Our capital allocation strategy remains disciplinedprioritizing investments that drive growth, applying excess cash flow to debt reduction when appropriate, and reinvesting in facilities, equipment, and technology to enhance our competitive position. Maintaining liquidity and flexibility will continue to be central as we pursue strategic opportunities and reinvest in the business."
- Kent Yee, Chief Financial Officer: "We are proud to announce the successful refinancing of $848 million, which includes our existing $643.0 million Term Loan B borrowings and an incremental $205 million. This transaction achieved several key objectives: repricing existing debt to generate an estimated $3.2 million in annual interest savings, enhancing liquidity, and creating flexibility to accelerate growth through acquisitions and strategic reinvestment. DXPs transformation over the past five years underscores our disciplined approachsales have grown from $1.0 billion in 2020 to $1.96 billion for the twelve months ended September 30, 2025, while covenant compliance adjusted EBITDA has increased from $64.9 million to over $225 million during the same period. We look forward to starting off 2026 with more acquisitions as we continue to scale DXP. We appreciate the continued support of our advisors and lender group."
Industry Context
The refinancing and incremental loan facility position DXP Enterprises, an industrial distribution expert, to continue its growth strategy, particularly through acquisitions. This move reflects a proactive approach to capital management, leveraging favorable debt markets to reduce interest costs and secure funds for expansion, which is a common strategy for companies in mature industrial sectors seeking to consolidate or expand market share.
Comparison to Industry Standards
- The repricing of existing debt to generate an estimated $3.2 million in annual interest savings suggests a favorable market for the company's credit, potentially indicating better terms than some industry peers might achieve or a strong negotiation position.
- The pro forma net debt to EBITDA of 2.8:1 at the end of Q3 2025 is a key leverage metric. While the filing does not provide direct comparisons, a ratio below 3.0-3.5x is generally considered healthy for industrial distribution companies, suggesting DXP's leverage is manageable and competitive within its sector.
- The growth in sales from $1.0 billion in 2020 to $1.96 billion for the twelve months ended September 30, 2025, and covenant compliance adjusted EBITDA from $64.9 million to over $225 million in the same period, demonstrates strong operational performance and growth, which could be seen as outperforming some industry benchmarks, especially given the economic conditions since 2020.
Stakeholder Impact
- Shareholders: Potential for increased shareholder value through strategic acquisitions, reinvestment, and improved financial flexibility. Reduced interest expense could positively impact earnings.
- Lenders: The existing and new lenders are part of a refinanced and expanded credit facility, indicating continued confidence in the company's financial health and growth prospects. The terms of the loan are favorable to the company.
- Employees: Continued growth and acquisitions could lead to expansion and opportunities for employees.
- Customers: Strategic reinvestment and acquisitions may lead to enhanced product and service offerings.
Next Steps
- Utilize proceeds to pay fees and transaction expenses associated with the closing of the Fourth Amendment.
- Finance permitted acquisitions.
- Replenish cash on the balance sheet and/or repay ABL Obligations incurred to finance permitted acquisitions.
- Use funds for other lawful, general corporate, limited liability company or partnership purposes, including permitted restricted payments, share repurchases, acquisitions, permitted capital expenditures, and other investments.
- Accelerate growth in 2026, including pursuing more acquisitions to scale DXP.
Key Dates
| Date | Description |
|---|---|
| 2020-12-23 | Original Term Loan and Security Agreement date. |
| 2022-11-22 | Effective date of Amendment No. 1 and Joinder Agreement to Term Loan and Security Agreement. |
| 2023-10-13 | Effective date of Amendment No. 2 and Joinder Agreement to Term Loan and Security Agreement, and the original maturity date for existing borrowings. |
| 2024-10-03 | Effective date of Amendment No. 3 and Joinder Agreement to Term Loan and Security Agreement. |
| 2025-09-30 | End of the twelve-month period for which sales and EBITDA figures are reported. |
| 2025-12-09 | Consent Deadline for Existing Term Lenders to execute and deliver a signature page to Amendment No. 4. |
| 2025-12-16 | Effective date of Amendment No. 4 and Joinder Agreement to Term Loan and Security Agreement (Fourth Amendment Effective Date/Closing Date). |
| 2025-12-22 | Date of the press release announcing the entry into the Term Loan Amendment. |
| 2030-10-13 | Maturity Date for the Term Loan B borrowings. |
Recommendation
strong buyThe filing details a highly favorable debt refinancing that significantly reduces annual interest expenses by $3.2 million and provides a substantial $205 million in incremental capital for strategic acquisitions and reinvestment. This move enhances the company's liquidity and financial flexibility, crucial for its stated goal of accelerating growth in 2026. The reported sales growth from $1.0 billion to $1.96 billion and a substantial increase in adjusted EBITDA from $64.9 million to over $225 million since 2020 demonstrate strong operational performance and a successful business transformation. The pro forma net debt to EBITDA of 2.8:1 indicates a healthy and manageable leverage profile. These factors collectively point to a company with robust financial health, a clear growth strategy, and improved cost structure, making it an attractive investment.
Keywords
Term Loan B, Refinancing, Incremental Term Loans, Debt, Liquidity, Acquisitions, Financial Covenants, Secured Leverage Ratio, EBITDA, DXP Enterprises, SOFR, Corporate Finance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.